Skip to main content

Table 1 Baseline characteristics of the cohort

From: Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort

Parameter Total Private practice Hospital-based units P value
Population (n) 1,591 492 1,099 -
Gender (%)     <0.001
Male 80.0 87.0 76.9  
Female 20.0 13.0 23.1  
Age (years) (median, range) 38 (18 to 78) 38 (19 to 69) 38 (18 to 78) 0.1
Nationality (%)     <0.001 (German versus others)
German 71.9 81.3 67.7  
Thai 2.4 0.8 3.1  
Turkish 2.3 2.0 2.5  
Cameroonian 2.2 0.4 3.0  
Kenyan 2.2 1.8 2.4  
Other (<2%) 18.6 13.3 20.9  
Missing data 0.4 0.4 0.4  
Ethnic origin (%)     <0.001 (Caucasian versus others)
Caucasian 81.2 89.0 77.7  
African 13.3 7.7 15.7  
Asian 3.5 1.0 4.6  
Other (<1%) 1.6 1.7 1.7  
Missing data 0.4 0.6 0.3  
HIV transmission groups (%)     <0.001 (MSM versus others)
MSM 52.5 68.3 45.5  
Heterosexual 18.7 12.2 21.7  
Endemic region 14.6 7.3 17.9  
Intravenous drug abuse 5.7 5.3 5.9  
Others (<1%) 1.6 0.4 2.0  
Missing data 6.9 6.5 7.0  
Duration of HIV-positivity (months) (median, range) 1 (0 to 260) 5 (0 to 260) 1 (0 to 244) <0.001
CDC stage (%)     0.042 (AIDS versus non-AIDS)
A 39.7 46.0 37.2  
B 26.9 26.5 27.1  
C 33.4 27.5 35.7  
CD4 cell count (CD4 cells/μL) (median, range) 210 (0 to 1,224) 246.5 (0 to 1,224) 189.5 (1 to 1,014) <0.001
Viral load (copies/mL) (median, range) 75,345.5 (227 to 5,022,690) 100,000 (227 to 5,022,690) 68,828 (508 to 500,000) 0.041
HIV-1 subtype: B 71.9 81.3 67.7 <0.001 (B versus others)
Transmitted drug resistance: resistance demonstrated 9.7 10.8 9.2 0.36 (resistance versus wild type)
  1. Values presented as percentages, unless otherwise indicated. CDC, Centers for Disease Control and Prevention; MSM, men who have sex with men.